1. Introduction {#sec1}
===============

Matrix metalloproteinases (MMPs) family enzymes can degrade extracellular matrix components by their proteolytic activity which depends on catalytic zinc ion \[[@B1]\]. The main role of macrophage metalloelastase (MMP-12) is degradation of elastin. Furthermore, MMP-12 is an interesting therapeutic target overexpressed in inflammatory pathological conditions (such as respiratory system diseases including asthma and chronic obstructive pulmonary disorder (COPD)) \[[@B2]\]. Effectiveness of MMP-12 inhibitors in reducing inflammation in respiratory system has been shown \[[@B3], [@B4]\].

The active site is highly conserved among MMPs with the exception of a loop region called S1′. S1′ pocket in MMPs active sites varies slightly among MMPs in both sequence and structure \[[@B5]\]. Despite available structural information, still the lack of selectivity remains as a main challenge for successfulness of MMPs inhibitors in clinical trials. Furthermore, intrinsic flexibility of MMPs active sites makes MMPs active site analysis more complicated \[[@B6], [@B7]\]. Therefore, in this study, a ligand based approach was used to modify the side chain in a series of MMP-12 inhibitors. HQSAR (hologram quantitative structure activity relationship) is a method for QSAR (quantitative structure activity relationship) studies whose reliability has been established \[[@B8]\]. In the present study, a HQSAR study on a series of tricycle cores containing MMP-12 inhibitors was carried out.

2. Methods {#sec2}
==========

2.1. Obtaining Biological Data and Generation of Molecular Structures {#sec2.1}
---------------------------------------------------------------------

The structures of 35 MMP-12 inhibitors and their biological activities for inhibition of MMP-12 were taken from the literatures ([Figure 1](#fig1){ref-type="fig"} and [Table 1](#tab1){ref-type="table"}) \[[@B9], [@B10]\]. As the activity of compound 10 is determined in both studies, we normalized the IC~50~ based on the reported activity for compound 10. The range of pIC~50~ (*µ*M) values for MMP-12 spans around three orders of magnitude (min = 1.6383, max = 4) in training set. The compounds were divided into two sets, training (*n* = 26) and test (*n* = 9) sets, according to the maintaining of structural diversity and the uniform distribution of IC~50~. The pIC~50~ (−Log IC~50~) was employed as dependent variable instead of IC~50~. The molecular structures were built using PyMOL (<http://www.pymol.org/>, The PyMOL Molecular Graphics System, Version 1.2r3pre, Schrödinger, LLC). The HQSAR model was developed by SYBYL-X1.2 molecular modeling package (Tripos International, St. Louis).

2.2. HQSAR Model Generation and Validation {#sec2.2}
------------------------------------------

HQSAR technique explores the contribution of each fragment of each molecule under study to the biological activity. As inputs, it needs datasets with their corresponding inhibitory activity in terms of pIC~50~. Structures in the dataset were fragmented and hashed into array bins. Molecular hologram fingerprints were then generated. Hologram was constructed by cutting the fingerprint into strings at various hologram length parameters.

After generation of descriptors, partial least square (PLS) methodology was used to find the possible correlation between dependent variable (−pIC~50~) and independent variable (descriptors generated by HQSAR structural features). LOO (leave-one-out) cross-validation method was used to determine the predictive value of the model. Optimum number of components was found out using results from LOO calculations. At this step, *q* ^2^ and standard error obtained from leave-one-out cross-validation roughly estimate the predictive ability of the model. This cross-validated analysis was followed by a non-cross-validated analysis with the calculated optimum number of principle components. Conventional correlation coefficient *r* ^2^ and standard error of estimate (SEE) indicated the validity of the model. The internal validity of the model was also tested by *Y*-randomization method \[[@B11]\]. In this test, the dependent variables are randomly shuffled while the independent variables (descriptors) are kept unchanged. It is expected that *q* ^2^ and *r* ^2^ calculated for these random datasets will be low. Finally, a set of compounds (which were not present in model development process) with available observed activity were used for external validation of the generated model. Predictive *r* ^2^ (*r* ~pred~ ^2^) value was calculated using $$\begin{matrix}
{r_{\text{pred}}^{2} = 1 - \frac{\text{PRESS}}{\text{SD}};} \\
\end{matrix}$$  PRESS: sum of the squared deviation between predicted and actual pIC~50~ for the test set compounds; SD: sum of the squared deviation between the actual pIC~50~ values of the compounds from the test set and the mean pIC~50~ value of the training set compounds.

The external validity of the model was also evaluated by Golbraikh-Tropsha \[[@B12]\] method and *r* ~*m*~ ^2^ \[[@B13]\] metrics. For an acceptable QSAR model, the value of "average *r* ~*m*~ ^2^" should be \>0.5 and "delta *r* ~*m*~ ^2^" should be \<0.2. The applicability domain of the generated model was evaluated for both test and prediction sets by Euclidean based method. It calculates a normalized mean distance score for each compound in training set in range of 0 (least diverse) to 1 (most diverse). Then, it calculates the normalized mean distance score for compounds in an external set. If a score is outside the 0 to 1 range, it will be considered outside of the applicability domain. The external validity tests (Golbraikh-Tropsha and Rm^2^) and applicability domain test were done using tools available at <http://dtclab.webs.com/software-tools>.

2.3. Prediction Set (Design of New Compounds) {#sec2.3}
---------------------------------------------

The prediction set contained 5 new not yet synthesized compounds having unknown observed values of activity against MMP-12. They were designed based on the prediction ability of developed HQSAR model.

2.4. Molecular Docking {#sec2.4}
----------------------

The molecular docking process was carried out employing Glide (Glide, version 5.7, Schrödinger, LLC, New York, NY, 2011) using default parameters. The protein (3F17) was prepared using Protein Preparation Wizard. Hydrogens were added, bond orders were assigned, overlapping hydrogens were corrected, missing side chains were added, and water molecules were removed. Finally, the protein structure was minimized by OPLS2005 force field. The prepared protein structure containing inhibitor molecule was used for active site definition (within 13 A from cocrystalized ligand). The 2D maps of ligands-receptor interactions were generated by ligand interaction diagram (Schrödinger molecular modeling suite).

3. Results {#sec3}
==========

3.1. HQSAR Model Predictivity {#sec3.1}
-----------------------------

The statistics for developed HQSAR model were shown in [Table 2](#tab2){ref-type="table"}. The statistical parameters, *q* ^2^, *r* ^2^, SEE, and *r* ~pred~ ^2^, showed the validity of our model. The best hologram model was generated using histogram length of 199 having six optimum components. Descriptors used for model generation were atoms, connections, and hydrogen atoms. The best generated model had cross-validated *q* ^2^ of 0.697 and non-cross-validated *r* ^2^ value of 0.986 with a standard error of 0.93. The total collection of the generated models for various histogram lengths comprises ensemble, and the ensemble value for *r* ^2^ was found to be 0.528. The *Y*-randomization results indicated that the calculated *q* ^2^ (−1.238, −0.303, −0.793, 0.081, and −0.146) and *r* ^2^ (0.683, 0.088, 0.086, 0.241, and 0.126) for five random models are very low which also confirm the internal validity of the generated HQSAR model. The results of *r* ~pred~ ^2^ calculation showed that the proposed HQSAR model was reliable and could successfully predict pIC~50~ for structurally related compounds which were not included in development of the models. The *r* ~*m*~ ^2^ (after scaling) was 0.825 and delta *r* ~*m*~ ^2^ was 0.107. Additionally, all four conditions of The Golbraikh-Tropsha method are satisfied (*r* ^2^ = 0.876). Predicted values for the activity of molecules are shown in [Table 1](#tab1){ref-type="table"} and the experimental pIC~50~ against the values predicted by the HQSAR models are plotted ([Figure 2](#fig2){ref-type="fig"}).

3.2. HQSAR Atomic Contribution Plot {#sec3.2}
-----------------------------------

The generated model can be accessed through atomic contribution plot. The various colors of each atom correspond to various degrees of contribution towards the overall biological activity. Red, red orange, and orange depicted that the color belonging atoms were contributing negatively to the generated HQSAR model while colors reflecting yellow, green, and green blue were contributing positively to the model. Intermediate contributions were reflected by gray atom. The maximum common substructure was shown in cyan. [Figure 3](#fig3){ref-type="fig"} depicts the contribution of the most potent compound 20 as well as compound 19.

3.3. Prediction Set (Design of New Virtual Compounds) {#sec3.3}
-----------------------------------------------------

This work allowed prediction of the activity of a set shown in [Table 3](#tab3){ref-type="table"} (not yet synthesized molecules). Their inhibitory activities were calculated according to the HQSAR model. They were designed based on compound 19 (one of the most active compounds). We had proposed a set of 5 new structures; some of them may show improved experimental MMP-12 inhibitory activity in comparison with the parent compound. This hypothesis and their selectivity should be verified experimentally.

3.4. Molecular Docking {#sec3.4}
----------------------

The molecular docking approach was employed to further analyze the ability of designed compounds in inhibition of MMP-12. In [Table 3](#tab3){ref-type="table"}, the docking scores of the 3 new designed compounds and 3 molecules from train set were reported. The binding positions of all new compounds were inspected for their binding conformation and interactions in MMP-12 active site. For n3, 2D diagram of ligand-receptor interaction was presented ([Figure 4(c)](#fig4){ref-type="fig"}). The various heterocyclic rings substituted on the dibenzofuran scaffold do not seem to have strong interactions with the binding pocket of MMP-12 as it was suggested previously by X-ray crystallography \[[@B9]\]. However, if they have undesired properties they cannot fit in the narrow deep S1′ pocket of MMP-12. On the other hand, they can induce steric hindrance that prevents other parts of the molecule to have strong interactions with residues in the binding pocket. The conformation of the heterocyclic ring upon ligand binding is demonstrated in [Figure 5](#fig5){ref-type="fig"}.

4. Discussion {#sec4}
=============

We successfully developed a HQSAR model for prediction of some MMP-12 inhibitors with good internal and external validity. Subsequently, the model was used to predict the activity of new MMP-12 inhibitors. The binding energy of new not yet synthesized molecules was evaluated by molecular docking.

Crystal structures have provided useful information for developing selective inhibitors toward particular MMPs including MMP-12. The segment 241--245 of MMPs (MMP-1 numbering) has the highest sequence variability among the various MMP enzymes and could be a target for designing selective inhibitors. However, this segment is very flexible which makes the molecular modeling predictions using 3D structures of MMPs inaccurate \[[@B14], [@B15]\]. Only some small differences in the sizes of hydrophobic side chains were seen. For example, Val 235 in MMP-12 is replaced by Leu214 in MMP-13 which makes the MMP-13 binding pocket smaller and more hydrophobic. The series of MMP-12 inhibitors employed in this study had carboxylic acid zinc binding group. Changing the R group that was placed in hydrophobic pocket of MMP-12 active site altered the potency and selectivity of these inhibitors. We modified this R group for fine tuning and designed new compound with promising MMP-12 inhibitory activity.

In the present study, we used HQSAR approach for a set of MMP-12 inhibitors. Contribution plot ([Figure 3](#fig3){ref-type="fig"}) showed that the green aromatic carbon was contributing positively to the model. Oxygen atom in furan ring was depicted by green or yellow and was contributing to the biological activity. Hydrogen molecules were rendered green, yellow, or white indicating that they showed intermediate contribution. The bulky group (methyl) was green indicating that it was contributing positively to the generated model, and it can be explained from the example that compound 20 was showing high potency. The developed model was used for the design of 5 new molecules. Overall docked conformation of the training set of inhibitors and new compounds in MMP-12 active site was similar to one determined by crystallography. Among new designed compounds, compounds n1, n2, and n3 had low SEP and their predicted activities were more reliable. Furthermore, compound n3 has the lowest docked energy.

5. Conclusion {#sec5}
=============

In summary, we have developed a reliable HQSAR model for a series of tricycle cores containing MMP-12 inhibitors with dibenzofuran ring using activity data reported earlier \[[@B9], [@B10]\]. We used HQSAR analysis to design new not yet synthesized potent MMP-12 inhibitors. Their binding energies were evaluated by docking studies but for further validation it needs synthesize of the proposed new compounds and subsequent enzyme inhibition study.
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![General structure for dataset.](IJMC2014-630807.001){#fig1}

![Plot of observed versus predicted activity obtained from HQSAR model for training and test sets.](IJMC2014-630807.002){#fig2}

![Contribution plot obtained from hologram quantitative structure activity relationship model for (a) compound 19 and (b) compound 20.](IJMC2014-630807.003){#fig3}

![2D interaction diagram of 3 docked designed compounds: (a) structure 26, (b) structure 20, and (c) structure n3.](IJMC2014-630807.004){#fig4}

![Compound 20 in the active site of MMP-12 (docked by Glide).](IJMC2014-630807.005){#fig5}

###### 

Actual and predicted activities of the training and test sets based on the HQSAR model. Activities were shown as pIC~50~ (*μ*M).

  Name    R                                    Actual pIC~50~ values   Predicted pIC~50~ values   Residues   Normalized mean distance score
  ------- ------------------------------------ ----------------------- -------------------------- ---------- --------------------------------
  10      ![](IJMC2014-630807.tab1.i001.jpg)   2.699                   2.594                      0.105      0.066
                                                                                                             
  11      ![](IJMC2014-630807.tab1.i002.jpg)   1.8861                  2.05                       −0.1639    0.028
                                                                                                             
  12      ![](IJMC2014-630807.tab1.i003.jpg)   1.8239                  2.144                      −0.3201    0.022
                                                                                                             
  13      ![](IJMC2014-630807.tab1.i004.jpg)   3.1549                  2.688                      0.4669     0.049
                                                                                                             
  14      ![](IJMC2014-630807.tab1.i005.jpg)   1.6383                  1.646                      −0.0077    0.332
                                                                                                             
  15^a^   ![](IJMC2014-630807.tab1.i006.jpg)   1.7447                  1.754                      −0.0093    0.065
                                                                                                             
  16      ![](IJMC2014-630807.tab1.i007.jpg)   2.6576                  2.672                      −0.0144    0.208
                                                                                                             
  19      ![](IJMC2014-630807.tab1.i008.jpg)   3.3979                  3.706                      −0.3081    0.037
                                                                                                             
  20      ![](IJMC2014-630807.tab1.i009.jpg)   4                       4.032                      −0.032     0.043
                                                                                                             
  21      ![](IJMC2014-630807.tab1.i010.jpg)   4                       3.778                      0.222      0.03
                                                                                                             
  22      ![](IJMC2014-630807.tab1.i011.jpg)   3.699                   3.647                      0.052      0.033
                                                                                                             
  23      ![](IJMC2014-630807.tab1.i012.jpg)   3.699                   3.752                      −0.053     0.031
                                                                                                             
  24      ![](IJMC2014-630807.tab1.i013.jpg)   3                       3.049                      −0.049     0.005
                                                                                                             
  25^a^   ![](IJMC2014-630807.tab1.i014.jpg)   3.3979                  3.17                       0.2279     0.085
                                                                                                             
  26      ![](IJMC2014-630807.tab1.i015.jpg)   3                       2.945                      0.055      0.009
                                                                                                             
  27      ![](IJMC2014-630807.tab1.i016.jpg)   2.9208                  2.949                      −0.0282    0.008
                                                                                                             
  33      Methyl                               2.0655                  2.341                      −0.2755    0
                                                                                                             
  34      Ethyl                                2.5376                  2.452                      0.0856     0.01
                                                                                                             
  35      i-Propyl                             2.3468                  2.423                      −0.0762    0.087
                                                                                                             
  36      t-Butyl                              1.7696                  1.839                      −0.0694    0.554
                                                                                                             
  37      i-Butyl                              2.2676                  2.203                      0.0646     0.284
                                                                                                             
  38      CH2OCH3                              2.7212                  2.571                      0.1502     0.007
                                                                                                             
  39      CF3                                  2.6576                  2.543                      0.1146     0
                                                                                                             
  40      Cyclopropyl                          2.7959                  2.767                      0.0289     0.08
                                                                                                             
  41      Cyclobutyl                           2.6383                  2.689                      −0.0507    0.377
                                                                                                             
  42      Cyclohexyl                           2.1427                  2.126                      0.0167     1
                                                                                                             
  43      Phenyl                               2.3979                  2.561                      −0.1631    0.116
                                                                                                             
  44      ![](IJMC2014-630807.tab1.i017.jpg)   3.5229                  3.491                      0.0319     0.186
                                                                                                             
  51^a^   ![](IJMC2014-630807.tab1.i018.jpg)   2.5441                  2.483                      0.0611     0.059
                                                                                                             
  52^a^   ![](IJMC2014-630807.tab1.i019.jpg)   2.0969                  2.502                      −0.4051    0.088
                                                                                                             
  53^a^   ![](IJMC2014-630807.tab1.i020.jpg)   2.173                   2.146                      0.027      0.297
                                                                                                             
  54^a^   ![](IJMC2014-630807.tab1.i021.jpg)   2.5229                  2.526                      −0.0031    0.049
                                                                                                             
  55^a^   ![](IJMC2014-630807.tab1.i022.jpg)   2.1461                  2.305                      −0.1589    0.324
                                                                                                             
  56^a^   ![](IJMC2014-630807.tab1.i023.jpg)   2.8909                  2.616                      0.2749      
                                                                                                             
  57^a^   ![](IJMC2014-630807.tab1.i024.jpg)   2.8037                  2.773                      0.0307     0.668

^a^Test set compounds.

###### 

Statistical characteristics of the developed HQSAR model.

  ------------------------------------------------------------------------
  Parameter                                               Value
  ------------------------------------------------------- ----------------
  Number of compounds included in training set            26

  Optimum number of components used in the PLS analysis   6

  *q* ^2^ (cross-validated correlation coefficient)       0.697

  SEE^a^ (*q* ^2^)                                        0.428

  *r* ^2^ (non-cross-validated correlation coefficient)   0.986

  SEE (*r* ^2^)                                           0.093

  *r* ^2^ (ensemble^b^)                                   0.528

  SEE (ensemble)                                          0.530

  Best hologram length                                    199

  Used information                                        Atoms\
                                                          + Connections\
                                                          + Hydrogen\
                                                          atoms

  *r* ~pred~ ^2^                                          0.8733
  ------------------------------------------------------------------------

^a^SEE: standard error of estimate. ^b^For each hologram length, a model could be established. The collection of these models comprises the ensemble.

###### 

Predicted activities for the molecules based on the HQSAR model. Activities were shown as pIC~50~ (*μ*M).

  Name                     R                                    Predicted pIC~50~ values   SE of prediction   Normalized mean distance score   Docking score
  ------------------------ ------------------------------------ -------------------------- ------------------ -------------------------------- ---------------
  n1                       ![](IJMC2014-630807.tab3.i001.jpg)   4.182                      0.158579           0.161                            −12.038972
                                                                                                                                               
  n2                       ![](IJMC2014-630807.tab3.i002.jpg)   3.89                       0.097741           0.076                            −13.92
                                                                                                                                               
  n3                       ![](IJMC2014-630807.tab3.i003.jpg)   3.942                      0.093502           0.072                            −13.87
                                                                                                                                               
  n4                       ![](IJMC2014-630807.tab3.i004.jpg)   3.846                      0.308627           0.291                            ---^a^
                                                                                                                                               
  n5                       ![](IJMC2014-630807.tab3.i005.jpg)   4.003                      0.325568           0.315                            ---^a^
                                                                                                                                               
  20 (observed = 4)        ![](IJMC2014-630807.tab3.i006.jpg)   4.032                      ---                0.043                            −13.7908
                                                                                                                                               
  19 (observed = 3.3979)   ![](IJMC2014-630807.tab3.i007.jpg)   3.706                      ---                0.037                            −12.555956
                                                                                                                                               
  26 (observed = 3)        ![](IJMC2014-630807.tab3.i008.jpg)   2.945                      ---                0.009                            −11.781243

^a^Docking was not performed for these compounds.
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